Celgene Corp Income Statement Quarterly
CELG
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2019) III. Quarter |
(Jun 30 2019) II. Quarter |
(Mar 31 2019) I. Quarter |
(Dec 31 2018) IV. Quarter |
(Sep 30 2018) III. Quarter |
Revenue From Contract With Customer Excluding Assessed Tax |
4,520.00 |
4,400.00 |
4,025.00 |
|
- |
Other Revenue, Net |
- |
- |
- |
|
- |
Revenue From Contract With Customer Excluding Assessed Tax |
- |
- |
- |
|
3,892.00 |
Total Revenue |
4,520.00 |
4,400.00 |
4,025.00 |
4,037.00 |
3,892.00 |
Cost of Goods and Services Sold |
167.00 |
151.00 |
140.00 |
304.00 |
157.00 |
Gross
Profit |
4,353.00 |
4,249.00 |
3,885.00 |
3,867.00 |
3,735.00 |
Selling, Administration, Marketing |
781.00 |
793.00 |
773.00 |
850.00 |
746.00 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research and Development Expense (Excluding Acquired in Process Cost) |
1,167.00 |
1,100.00 |
1,216.00 |
1,138.00 |
1,081.00 |
Business Combination, Acquisition Related Costs |
32.00 |
136.00 |
77.00 |
-54.00 |
101.00 |
Other exp. /-income |
- |
- |
- |
- |
- |
Special Items |
- |
- |
- |
- |
- |
Amortization of Intangible Assets Acquired |
109.00 |
109.00 |
109.00 |
- |
127.00 |
Total operating costs including COS |
2,256.00 |
2,289.00 |
2,315.00 |
2,230.00 |
2,212.00 |
Operating income/-loss
|
2,264.00 |
2,111.00 |
1,710.00 |
1,807.00 |
1,680.00 |
Other Deductions / - Income |
Interest expense |
190.00 |
192.00 |
192.00 |
-574.00 |
193.00 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
190.00 |
192.00 |
192.00 |
190.00 |
193.00 |
Investment Income, Interest and Dividend |
- |
- |
- |
33.00 |
- |
Income from affiliates |
- |
- |
- |
- |
- |
Sale of Business |
- |
- |
- |
- |
- |
Financing Loss/ -Income |
- |
- |
- |
- |
- |
Other loss/ -income |
157.00 |
98.00 |
-296.00 |
500.00 |
109.00 |
Total costs & expenses |
2,603.00 |
2,579.00 |
2,211.00 |
2,230.00 |
2,514.00 |
Income /-loss before income taxes |
1,917.00 |
1,821.00 |
1,814.00 |
1,117.00 |
1,378.00 |
Income taxes expenses/-benefit |
226.00 |
250.00 |
269.00 |
44.00 |
296.00 |
Income after income taxes |
1,691.00 |
1,571.00 |
1,545.00 |
1,073.00 |
1,082.00 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
1,691.00 |
1,571.00 |
1,545.00 |
1,073.00 |
1,082.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
1,691.00 |
1,571.00 |
1,545.00 |
-2,973.00 |
1,082.00 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
1,691.00 |
1,571.00 |
1,545.00 |
1,073.00 |
1,082.00 |
EBIT |
2,107.00 |
2,013.00 |
2,006.00 |
1,307.00 |
1,571.00 |
EBITD |
2,155.00 |
2,060.00 |
2,053.00 |
1,348.00 |
1,611.00 |
EBITDA |
2,155.00 |
2,060.00 |
2,053.00 |
1,823.00 |
1,611.00 |
Per
Share (GAAP Quarterly, in $) |
(Sep 30 2019) III. Quarter |
(Jun 30 2019) II. Quarter |
(Mar 31 2019) I. Quarter |
(Dec 31 2018) IV. Quarter |
(Sep 30 2018) III. Quarter |
Basic EPS (excl. extra
items) |
2.38 |
2.22 |
2.20 |
1.54 |
1.54 |
Extraordinary items |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Basic Net EPS |
2.38 |
2.22 |
2.20 |
1.53 |
1.54 |
Basic shares outstanding (Mill.
of Units) |
709.40 |
706.70 |
702.40 |
699.50 |
702.00 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
2.32 |
2.16 |
2.14 |
1.50 |
1.50 |
Diluted average shares (Mill.
of Units) |
729.50 |
726.70 |
720.50 |
713.90 |
719.70 |
Dividend per share |
- |
- |
- |
- |
- |
|
|